Nom |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-méthyl-, (5a,17b)- |
Synonymes |
2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-méthyl- (8CI) ; Cyclopenta[7,8]phénanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadécahydro-1,10a,12a-triméthyl-(6CI,7CI) ; 17-méthyl-5a-androstano[3,2-c]pyrazol-17b-ol ; 17-méthyl-pyrazolo[4',3' :2,3]-5a-androstan-17b-ol ; 17a-méthyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole ; 17b-hydroxy-17-méthyl-5a-androstano[3,2-c]pyrazole ; 17b-hydroxy-17a-méthyl-5a-androstano[3,2-c]pyrazole ; Anabol ; Androstanazol ; Androstanazole ; l’androstanazolestanazol ; Estazol ; NSC233046 ; Stanabolique ; le stanazolol ; le stanozolol ; Stromba ; Strombaject ; Tevabolin ; Victoire 14833 ; Winstroïde ; Winstrol ; Dépôt de Winstrol ; Winstrol V |
Nom anglais |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-;2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol; 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol; 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole; 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC233046; Stanabolic; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V |
Formule moléculaire |
C21H32N2O |
Poids Moléculaire |
328.55 |
Numéro de registre CAS |
302-96-5 |
Structure moléculaire |
|
Densité |
1.129g/cm3 |
Point d'ébullition |
490.8°Cat760mmHg |
Point d'éclair |
250.7°C |
Les symboles de danger |
|
Codes des risques |
|
Description de sécurité |
x." target="_blank">Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.:;
|
|